Radiofrequency Ablation for BIII Thyroid Nodules
Recruiting now
Conditions studied: Indeterminate Bethesda III Thyroid Nodules
In brief
The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.
Key facts
- Study ID
- NCT05189808
- Run by
- Columbia University
- People needed
- 50
- Starts
- 2020-08-01
- Expected to finish
- 2028-08-01
- Last updated by the study team
- 2026-05-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests
You may not qualify if…
- cardiac arrthymias
- pregnancy
Where it is running
- Columbia University — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.